Industry: Medical Devices & Consumables
Published Date: 2024-12-12
Pages: 170 Pages
Report ld: 3401604
Request Sample
Customized Report
Clinical IVD Reagents Market Size(US$)

CAGR 2024-2030
4.8%
Market Size,2030
USD 1,998
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Clinical IVD Reagents revenue was US$ 1463 million in 2023 and is forecast to a readjusted size of US$ 1998 million by 2030 with a CAGR of 4.8% during the review period (2024-2030).
In United States the Clinical IVD Reagents revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Clinical IVD Reagents market, also covers the segmentation data of other regions in regional level and county level.
Clinical In Vitro Diagnostic (IVD) Reagents are substances or compounds used in laboratory tests to detect, monitor, or diagnose diseases or medical conditions in biological samples (such as blood, urine, saliva, or tissues). These reagents are part of in vitro diagnostic (IVD) tests, which are performed outside the body (in vitro), typically in a clinical or laboratory setting, to analyze samples and provide valuable health information.
The global key players of Clinical IVD Reagents include Danaher, Roche, Abbott, Siemen, Thermo Fisher Scientific, Illumina, BioMerieux, BD, Hologic, Bio-Rad, etc. The global five biggest players hold a share of % in 2023.
Clinical IVD Reagents market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Clinical IVD Reagents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Clinical IVD Reagents market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces Clinical IVD Reagents definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Clinical IVD Reagents companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Clinical IVD Reagents in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical IVD Reagents sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Clinical IVD Reagents Product Introduction
1.2 Global Clinical IVD Reagents Outlook 2019 VS 2023 VS 2030
1.2.1 Global Clinical IVD Reagents Sales in US$ Million for the Year 2019-2030
1.2.2 Global Clinical IVD Reagents Sales in Volume for the Year 2019-2030
1.3 United States Clinical IVD Reagents Outlook 2019 VS 2023 VS 2030
1.3.1 United States Clinical IVD Reagents Sales in US$ Million for the Year 2019-2030
1.3.2 United States Clinical IVD Reagents Sales in Volume for the Year 2019-2030
1.4 Clinical IVD Reagents Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Clinical IVD Reagents in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Clinical IVD Reagents Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Clinical IVD Reagents Market Dynamics
1.5.1 Clinical IVD Reagents Industry Trends
1.5.2 Clinical IVD Reagents Market Drivers
1.5.3 Clinical IVD Reagents Market Challenges
1.5.4 Clinical IVD Reagents Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Clinical IVD Reagents by Type
2.1 Clinical IVD Reagents Market by Type
2.1.1 Antibodies
2.1.2 Antigens, Purified Proteins and Peptides
2.1.3 Olignucleotides
2.1.4 Others
2.2 Global Clinical IVD Reagents Market Size by Type
2.2.1 Global Clinical IVD Reagents Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Clinical IVD Reagents Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Clinical IVD Reagents Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Clinical IVD Reagents Market Size by Type
2.3.1 United States Clinical IVD Reagents Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Clinical IVD Reagents Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Clinical IVD Reagents Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Clinical IVD Reagents by Application
3.1 Clinical IVD Reagents Market by Application
3.1.1 Infectious Diseases
3.1.2 Oncology Applications
3.1.3 Endocrinology
3.1.4 Blood Sreening
3.1.5 Others
3.2 Global Clinical IVD Reagents Market Size by Application
3.2.1 Global Clinical IVD Reagents Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Clinical IVD Reagents Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Clinical IVD Reagents Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Clinical IVD Reagents Market Size by Application
3.3.1 United States Clinical IVD Reagents Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Clinical IVD Reagents Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Clinical IVD Reagents Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Clinical IVD Reagents Competitor Landscape by Company
4.1 Global Clinical IVD Reagents Market Size by Company
4.1.1 Global Key Manufacturers of Clinical IVD Reagents, Ranked by Revenue (2023)
4.1.2 Global Clinical IVD Reagents Revenue by Manufacturer (2019-2024)
4.1.3 Global Clinical IVD Reagents Sales by Manufacturer (2019-2024)
4.1.4 Global Clinical IVD Reagents Price by Manufacturer (2019-2024)
4.2 Global Clinical IVD Reagents Concentration Ratio (CR)
4.2.1 Clinical IVD Reagents Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Clinical IVD Reagents in 2023
4.2.3 Global Clinical IVD Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Clinical IVD Reagents, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Clinical IVD Reagents, Product Offered and Application
4.5 Global Key Manufacturers of Clinical IVD Reagents, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Clinical IVD Reagents Market Size by Company
4.7.1 Key Players of Clinical IVD Reagents in United States, Ranked by Revenue (2023)
4.7.2 United States Clinical IVD Reagents Revenue by Players (2019-2024)
4.7.3 United States Clinical IVD Reagents Sales by Players (2019-2024)
5 Global Clinical IVD Reagents Market Size by Region
5.1 Global Clinical IVD Reagents Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Clinical IVD Reagents Market Size in Volume by Region (2019-2030)
5.2.1 Global Clinical IVD Reagents Sales in Volume by Region: 2019-2024
5.2.2 Global Clinical IVD Reagents Sales in Volume Forecast by Region (2025-2030)
5.3 Global Clinical IVD Reagents Market Size in Value by Region (2019-2030)
5.3.1 Global Clinical IVD Reagents Sales in Value by Region: 2019-2024
5.3.2 Global Clinical IVD Reagents Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Clinical IVD Reagents Market Size YoY Growth 2019-2030
6.2 Americas Clinical IVD Reagents Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Clinical IVD Reagents Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Clinical IVD Reagents Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Clinical IVD Reagents Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Clinical IVD Reagents Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Clinical IVD Reagents Market Size YoY Growth 2019-2030
7.2 EMEA Clinical IVD Reagents Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Clinical IVD Reagents Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Clinical IVD Reagents Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Clinical IVD Reagents Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Clinical IVD Reagents Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Clinical IVD Reagents Market Size YoY Growth 2019-2030
8.2 China Clinical IVD Reagents Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Clinical IVD Reagents Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Clinical IVD Reagents Market Size YoY Growth 2019-2030
9.2 APAC Clinical IVD Reagents Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Clinical IVD Reagents Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Clinical IVD Reagents Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Clinical IVD Reagents Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Clinical IVD Reagents Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Danaher
10.1.1 Danaher Company Information
10.1.2 Danaher Description and Business Overview
10.1.3 Danaher Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.1.4 Danaher Clinical IVD Reagents Products Offered
10.1.5 Danaher Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Description and Business Overview
10.2.3 Roche Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Roche Clinical IVD Reagents Products Offered
10.2.5 Roche Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Description and Business Overview
10.3.3 Abbott Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.3.4 Abbott Clinical IVD Reagents Products Offered
10.3.5 Abbott Recent Development
10.4 Siemen
10.4.1 Siemen Company Information
10.4.2 Siemen Description and Business Overview
10.4.3 Siemen Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.4.4 Siemen Clinical IVD Reagents Products Offered
10.4.5 Siemen Recent Development
10.5 Thermo Fisher Scientific
10.5.1 Thermo Fisher Scientific Company Information
10.5.2 Thermo Fisher Scientific Description and Business Overview
10.5.3 Thermo Fisher Scientific Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.5.4 Thermo Fisher Scientific Clinical IVD Reagents Products Offered
10.5.5 Thermo Fisher Scientific Recent Development
10.6 Illumina
10.6.1 Illumina Company Information
10.6.2 Illumina Description and Business Overview
10.6.3 Illumina Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.6.4 Illumina Clinical IVD Reagents Products Offered
10.6.5 Illumina Recent Development
10.7 BioMerieux
10.7.1 BioMerieux Company Information
10.7.2 BioMerieux Description and Business Overview
10.7.3 BioMerieux Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.7.4 BioMerieux Clinical IVD Reagents Products Offered
10.7.5 BioMerieux Recent Development
10.8 BD
10.8.1 BD Company Information
10.8.2 BD Description and Business Overview
10.8.3 BD Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.8.4 BD Clinical IVD Reagents Products Offered
10.8.5 BD Recent Development
10.9 Hologic
10.9.1 Hologic Company Information
10.9.2 Hologic Description and Business Overview
10.9.3 Hologic Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.9.4 Hologic Clinical IVD Reagents Products Offered
10.9.5 Hologic Recent Development
10.10 Bio-Rad
10.10.1 Bio-Rad Company Information
10.10.2 Bio-Rad Description and Business Overview
10.10.3 Bio-Rad Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.10.4 Bio-Rad Clinical IVD Reagents Products Offered
10.10.5 Bio-Rad Recent Development
10.11 Sysmex
10.11.1 Sysmex Company Information
10.11.2 Sysmex Description and Business Overview
10.11.3 Sysmex Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.11.4 Sysmex Clinical IVD Reagents Products Offered
10.11.5 Sysmex Recent Development
10.12 QIAGEN
10.12.1 QIAGEN Company Information
10.12.2 QIAGEN Description and Business Overview
10.12.3 QIAGEN Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.12.4 QIAGEN Clinical IVD Reagents Products Offered
10.12.5 QIAGEN Recent Development
10.13 Agilent
10.13.1 Agilent Company Information
10.13.2 Agilent Description and Business Overview
10.13.3 Agilent Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.13.4 Agilent Clinical IVD Reagents Products Offered
10.13.5 Agilent Recent Development
10.14 Revvity
10.14.1 Revvity Company Information
10.14.2 Revvity Description and Business Overview
10.14.3 Revvity Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.14.4 Revvity Clinical IVD Reagents Products Offered
10.14.5 Revvity Recent Development
10.15 DiaSorin
10.15.1 DiaSorin Company Information
10.15.2 DiaSorin Description and Business Overview
10.15.3 DiaSorin Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.15.4 DiaSorin Clinical IVD Reagents Products Offered
10.15.5 DiaSorin Recent Development
10.16 Grifols
10.16.1 Grifols Company Information
10.16.2 Grifols Description and Business Overview
10.16.3 Grifols Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.16.4 Grifols Clinical IVD Reagents Products Offered
10.16.5 Grifols Recent Development
10.17 Werfen
10.17.1 Werfen Company Information
10.17.2 Werfen Description and Business Overview
10.17.3 Werfen Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.17.4 Werfen Clinical IVD Reagents Products Offered
10.17.5 Werfen Recent Development
10.18 QuidelOrtho
10.18.1 QuidelOrtho Company Information
10.18.2 QuidelOrtho Description and Business Overview
10.18.3 QuidelOrtho Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.18.4 QuidelOrtho Clinical IVD Reagents Products Offered
10.18.5 QuidelOrtho Recent Development
10.19 Chembio Diagnostics
10.19.1 Chembio Diagnostics Company Information
10.19.2 Chembio Diagnostics Description and Business Overview
10.19.3 Chembio Diagnostics Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.19.4 Chembio Diagnostics Clinical IVD Reagents Products Offered
10.19.5 Chembio Diagnostics Recent Development
10.20 Surmodics
10.20.1 Surmodics Company Information
10.20.2 Surmodics Description and Business Overview
10.20.3 Surmodics Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.20.4 Surmodics Clinical IVD Reagents Products Offered
10.20.5 Surmodics Recent Development
10.21 Merck KGaA
10.21.1 Merck KGaA Company Information
10.21.2 Merck KGaA Description and Business Overview
10.21.3 Merck KGaA Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.21.4 Merck KGaA Clinical IVD Reagents Products Offered
10.21.5 Merck KGaA Recent Development
10.22 MBL Life Science
10.22.1 MBL Life Science Company Information
10.22.2 MBL Life Science Description and Business Overview
10.22.3 MBL Life Science Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.22.4 MBL Life Science Clinical IVD Reagents Products Offered
10.22.5 MBL Life Science Recent Development
10.23 Canvax
10.23.1 Canvax Company Information
10.23.2 Canvax Description and Business Overview
10.23.3 Canvax Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.23.4 Canvax Clinical IVD Reagents Products Offered
10.23.5 Canvax Recent Development
10.24 Prestige Diagnostics
10.24.1 Prestige Diagnostics Company Information
10.24.2 Prestige Diagnostics Description and Business Overview
10.24.3 Prestige Diagnostics Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.24.4 Prestige Diagnostics Clinical IVD Reagents Products Offered
10.24.5 Prestige Diagnostics Recent Development
10.25 Adaltis
10.25.1 Adaltis Company Information
10.25.2 Adaltis Description and Business Overview
10.25.3 Adaltis Clinical IVD Reagents Sales, Revenue and Gross Margin (2019-2024)
10.25.4 Adaltis Clinical IVD Reagents Products Offered
10.25.5 Adaltis Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Clinical IVD Reagents Industry Chain Analysis
11.2 Clinical IVD Reagents Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Clinical IVD Reagents Production Mode & Process
11.4 Clinical IVD Reagents Sales and Marketing
11.4.1 Clinical IVD Reagents Sales Channels
11.4.2 Clinical IVD Reagents Distributors
11.5 Clinical IVD Reagents Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Clinical IVD Reagents was estimated to be worth US$ 75266 million in 2025 and is projected to reach US$ 99974 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-05-02
Pages: 151
USD 3950.00
(Single User License)
The global Clinical IVD Reagents market is projected to grow from US$ 75266 million in 2025 to US$ 99974 million by 2032, at a CAGR of 4.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-05-02
Pages: 168
USD 4900.00
(Single User License)
The global Clinical IVD Reagents market size was US$ 75266 million in 2025 and is forecast to reach a readjusted size of US$ 99974 million by 2032 with a CAGR of 4.2% during the forecast period 2026-2032.
Published Date: 2026-05-02
Pages: 144
USD 4250.00
(Single User License)
The global Clinical IVD Reagents market was valued at US$ 75266 million in 2025 and is anticipated to reach US$ 99974 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published Date: 2026-05-02
Pages: 142
USD 2900.00
(Single User License)
The global market for Clinical IVD Reagents was estimated to be worth US$ 1573 million in 2025 and is projected to reach US$ 2175 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 162
USD 3950.00
(Single User License)
The global Clinical IVD Reagents market size was US$ 1508 million in 2024 and is forecast to a readjusted size of US$ 2085 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 111
USD 4250.00
(Single User License)
The global Clinical IVD Reagents market is projected to grow from US$ 1508 million in 2024 to US$ 2085 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 197
USD 4900.00
(Single User License)
The global market for Clinical IVD Reagents was estimated to be worth US$ 1508 million in 2024 and is forecast to a readjusted size of US$ 2085 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 160
USD 3950.00
(Single User License)
The global market for Clinical IVD Reagents was valued at US$ 1508 million in the year 2024 and is projected to reach a revised size of US$ 2085 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published Date: 2025-03-10
Pages: 111
USD 2900.00
(Single User License)
Valued at US$ 1508 million in 2024, the global Clinical IVD Reagents market is forecast to reach US$ 1998 million by 2030, at a CAGR of 4.8% during the forecast period.
Published Date: 2024-12-12
Pages: 189
USD 4900.00
(Single User License)
The global market for Clinical IVD Reagents was estimated to be worth US$ 75266 million in 2025 and is projected to reach US$ 99974 million, growing at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-05-02
Pages: 151
The global Clinical IVD Reagents market is projected to grow from US$ 75266 million in 2025 to US$ 99974 million by 2032, at a CAGR of 4.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-05-02
Pages: 168
The global Clinical IVD Reagents market size was US$ 75266 million in 2025 and is forecast to reach a readjusted size of US$ 99974 million by 2032 with a CAGR of 4.2% during the forecast period 2026-2032.
Published: 2026-05-02
Pages: 144
The global Clinical IVD Reagents market was valued at US$ 75266 million in 2025 and is anticipated to reach US$ 99974 million by 2032, at a CAGR of 4.2% from 2026 to 2032.
Published: 2026-05-02
Pages: 142
The global market for Clinical IVD Reagents was estimated to be worth US$ 1573 million in 2025 and is projected to reach US$ 2175 million, growing at a CAGR of 4.8% from 2026 to 2032.
Published: 2026-01-19
Pages: 162
The global Clinical IVD Reagents market size was US$ 1508 million in 2024 and is forecast to a readjusted size of US$ 2085 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 111
The global Clinical IVD Reagents market is projected to grow from US$ 1508 million in 2024 to US$ 2085 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 197
The global market for Clinical IVD Reagents was estimated to be worth US$ 1508 million in 2024 and is forecast to a readjusted size of US$ 2085 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 160
The global market for Clinical IVD Reagents was valued at US$ 1508 million in the year 2024 and is projected to reach a revised size of US$ 2085 million by 2031, growing at a CAGR of 4.8% during the forecast period.
Published: 2025-03-10
Pages: 111
Valued at US$ 1508 million in 2024, the global Clinical IVD Reagents market is forecast to reach US$ 1998 million by 2030, at a CAGR of 4.8% during the forecast period.
Published: 2024-12-12
Pages: 189
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now